Akari clinical data from 38 subjects (in previous clinical studies and healthy volunteers) support robust PK/PD model simulations used to select doses for nomacopan Phase 3 Part A clinical trial in HSCT-TMA, currently underway. #TMA
Rich Database Underpins Predictive PK/PD Model
